GeneBioTech Co Ltd banner
G

GeneBioTech Co Ltd
KOSDAQ:086060

Watchlist Manager
GeneBioTech Co Ltd
KOSDAQ:086060
Watchlist
Price: 4 885 KRW -0.61% Market Closed
Market Cap: ₩42.1B

GeneBioTech Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

GeneBioTech Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
G
GeneBioTech Co Ltd
KOSDAQ:086060
EPS (Diluted)
₩427
CAGR 3-Years
76%
CAGR 5-Years
34%
CAGR 10-Years
5%
Celltrion Inc
KRX:068270
EPS (Diluted)
₩4.7k
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
17%
O
OliX Pharmaceuticals Inc
KOSDAQ:226950
EPS (Diluted)
-₩800
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
EPS (Diluted)
-₩1.9k
CAGR 3-Years
-14%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
EPS (Diluted)
₩2.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
55%
A
ABL Bio Inc
KOSDAQ:298380
EPS (Diluted)
-₩734
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

GeneBioTech Co Ltd
Glance View

Market Cap
42.1B KRW
Industry
Biotechnology

Gene Bio Tech Co., Ltd. engages in the manufacture of fermented biomass. The company is headquartered in Gongju, Chungcheongnam-Do. The company went IPO on 2006-04-28. is a company mainly engaged in the production and sale of feed additives and animal drugs. Along with subsidiaries, the Company operates its business through two segments. The Additive segment is involved in the manufacturing and sale of fermented products and bio starches. The Animal Drug segment is involved in the manufacturing and sale of livestock and fish medicine. The main products include vitamins, minerals, antibiotics, nutrients, immune stimulators, digestion and absorption promoters, among others. The firm distributes its products within the domestic market and to overseas markets, including America.

GeneBioTech Co Ltd Intrinsic Value
LOCKED
Unlock

See Also

What is GeneBioTech Co Ltd's EPS (Diluted)?
EPS (Diluted)
427.6 KRW

Based on the financial report for Sep 30, 2025, GeneBioTech Co Ltd's EPS (Diluted) amounts to 427.6 KRW.

What is GeneBioTech Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
5%

Over the last year, the EPS (Diluted) growth was 44%. The average annual EPS (Diluted) growth rates for GeneBioTech Co Ltd have been 76% over the past three years , 34% over the past five years , and 5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett